Codex can exploit vulnerable crypto smart contracts 72% of the time, raising urgent questions about AI-powered cyber offense and defense.

Veeva Systems (NYSE:VEEV) is one of the best 52-week low blue-chip stocks to buy right now. On January 29, Veeva Systems (NYSE:VEEV) unveiled Veeva eSource, a new Veeva SiteVault tailored to eliminate ...

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Veeva Systems (NYSE:VEEV) reports that 13 of the top 20 ...

As noted previously, when Veeva ended its licence agreement with Salesforce, it not only triggered a battle royale for domination of big pharma CRM, it began the first massive use case for adoption of ...

The latest announcement is out from Veeva Systems ( (VEEV)). On January 5, 2026, Veeva Systems announced that its board had authorized the company’s first-ever share repurchase program, allowing the ...

The Details: Veeva reported quarterly earnings of $2.04 per share, which beat the analyst estimate of $1.95. Quarterly revenue of $811.2 million beat the Street estimate of $792.82 million.

Veeva Systems Inc. (NYSE:VEEV) is one of the best digital health stocks to buy now. On November 4, 2025, Veeva announced that its Veeva Basics solution has been adopted by “more than 100 biotechs” to ...

Amgen will employ the Veeva Clinical Platform to support and identify efficiencies across the clinical trial process. "We're excited to help Amgen further advance clinical development. Veeva Clinical ...

Veeva Systems has unveiled its first big biotech pact since thawing relations with one-time adversary IQVIA, teaming up with Amgen to find ways to improve clinical trial processes. Amgen will take ...